Transfusion Independence Achieved with Combination Fedratinib and Luspatercept in an Elderly Man with Heavily Pretreated Intermediate-2 Risk Primary Myelofibrosis

Myelofibrosis (MF)-associated anemia and transfusion dependency are associated with inferior quality of life and poor prognosis. JAK2 inhibitors and TGF-β superfamily ligand traps are being explored as treatment options for MF-associated anemia. Here, we present the case of a 66-year-old man with he...

Descripción completa

Detalles Bibliográficos
Autores principales: Yun, Nicole K., Alrifai, Taha, Miller, Ira J., Shammo, Jamile M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921965/
https://www.ncbi.nlm.nih.gov/pubmed/35350804
http://dx.doi.org/10.1159/000521889

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921965/
https://www.ncbi.nlm.nih.gov/pubmed/35350804
http://dx.doi.org/10.1159/000521889

Ejemplares similares